Last reviewed · How we verify

Ceresine — Competitive Intelligence Brief

Ceresine (DICHLOROACETIC ACID) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: dichloroacetic acid. Area: Other.

phase 3 dichloroacetic acid [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial Other Small molecule Live · refreshed every 30 min

Target snapshot

Ceresine (DICHLOROACETIC ACID). Ceresine works by inhibiting an enzyme involved in energy production in cells, which can help to treat warts.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ceresine TARGET DICHLOROACETIC ACID phase 3 dichloroacetic acid [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (dichloroacetic acid class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ceresine — Competitive Intelligence Brief. https://druglandscape.com/ci/dichloroacetic-acid. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing